Search by Drug Name or NDC
NDC 58809-0190-16 VanaCof 2 12.5; 1 mg/5mL; mg/5mL Details
VanaCof 2 12.5; 1 mg/5mL; mg/5mL
VanaCof 2 is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by GM Pharmaceuticals, INC. The primary component is CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE.
Product Information
| NDC | 58809-0190 |
|---|---|
| Product ID | 58809-190_0c7f3f80-b27d-9526-e063-6394a90a7a1c |
| Associated GPIs | |
| GCN Sequence Number | 085640 |
| GCN Sequence Number Description | dexchlorpheniram/chlophedianol LIQUID 1-12.5MG/5 ORAL |
| HIC3 | B4E |
| HIC3 Description | NON-OPIOID ANTITUSSIVE-1ST GEN ANTIHISTAMINE COMB. |
| GCN | 55157 |
| HICL Sequence Number | 049358 |
| HICL Sequence Number Description | DEXCHLORPHENIRAMINE MALEATE/CHLOPHEDIANOL HCL |
| Brand/Generic | Brand |
| Proprietary Name | VanaCof 2 |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Chlophedianol HCI, Dexchlorpheniramine Maleate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 12.5; 1 |
| Active Ingredient Units | mg/5mL; mg/5mL |
| Substance Name | CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE |
| Labeler Name | GM Pharmaceuticals, INC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M012 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 58809-0190-16 (58809019016)
| NDC Package Code | 58809-190-16 |
|---|---|
| Billing NDC | 58809019016 |
| Package | 473 mL in 1 BOTTLE (58809-190-16) |
| Marketing Start Date | 2023-12-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |